Kiran Mazumdar-Shaw founded Immuneel Therapeutics raises Rs 100 Cr in Series B Funding (opens original article in a new tab)

Kiran Mazumdar-Shaw's Immuneel Therapeutics raised Rs 100 Cr in Series B funding for expanding manufacturing, R&D, and international operations.

• Immuneel Therapeutics raised Rs 100 Cr in Series B funding
• Funding will be used for expanding manufacturing capacity
• Funding will support R&D and international expansion